Anthropic on Tuesday gave approximately 150 organizations around the world access to Mythos, its powerful new AI model whose ...

EPFL researchers are developing AI models that could one day enable vision prosthetics able to restore meaningful, ...

This practice had to change when the European Union introduced Right to be Forgotten (RTBF)—first in 2014, as a standalone right applicable to online search engines and then in 2018, as a universal ...

Python stays far ahead after another dip; C holds second, Java retakes third from C++, and R rises to eighth as SQL slips, ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...

Learning a programming language usually involves staring at documentation until your eyes glaze over. But what if you could turn those dry technical PDFs into an engaging conversation? That is exactly ...

User-defined instructions (UDIs) let engineers write logic once and reuse it across many components, eliminating tedious copy-paste duplication. Any updates to a UDI definition automatically propagate ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...

New data suggest a link between using GLP-1 receptor agonists (GLP-1 RAs) and a significantly higher risk for tendon ruptures, primarily tears involving the rotator cuff, Achilles, and pectoralis ...

New findings show a link between GLP-1 use and a lower risk of severe migraines. Researchers looked at nearly 22,000 patients and compared the hospital records of those on GLP-1 drugs with those of a ...

GLP-1 receptor agonists improve glycemic control and weight while reducing cardiovascular events, with tolerability limited by gastrointestinal adverse effects requiring gradual dose escalation.